Skip to main content

Month: April 2021

H&E Equipment Services Announces 2021 First Quarter Earnings and Conference Call Date

BATON ROUGE, La., April 20, 2021 (GLOBE NEWSWIRE) — H&E Equipment Services, Inc. (NASDAQ: HEES) today announced that it will release its 2021 first quarter financial results before the market on Tuesday, April 27, 2021.  The Company will also hold a conference call to discuss first quarter results on Tuesday, April 27, 2021, at 10:00 a.m. (Eastern Time).  To listen to the call, participants should dial 877-317-6789 approximately 10 minutes prior to the start of the call.  A telephonic replay will become available after 1:00 p.m. (Eastern Time) on April 27, 2021, and will continue through May 4, 2021, by dialing 877-344-7529 and entering the confirmation code 10153911. The live broadcast of H&E Equipment Services’ quarterly conference call will be available online at www.he-equipment.com on April 27, beginning at 10:00 a.m....

Continue reading

Effnetplattformen AB (publ): Kallelse till årsstämma i Effnetplattformen AB

Stockholm, 20 april 2021 — Aktieägarna i Effnetplattformen AB (publ), org.nr. 559085-5721, (”Effnetplattformen”) kallas till årsstämma fredagen den 21 maj 2021. Med anledning av den rådande situationen rörande spridningen av coronaviruset har styrelsen för Effnetplattformen, i enlighet med lagen (2020:198) om tillfälliga undantag för att underlätta genomförandet av bolags- och föreningsstämmor, beslutat att bolagsstämman ska genomföras enligt ett s.k. poströstningsförfarande. Bolagsstämman hålls därmed utan möjlighet för aktieägare att närvara personligen eller genom ombud. I stället kan aktieägare delta vid bolagsstämman genom att rösta och lämna in frågor i förväg enligt instruktionerna nedan. Information om de beslut som har fattats av bolagsstämman offentliggörs fredagen den 21 maj 2021 så snart utfallet av poströstningen är...

Continue reading

New research from Willis Towers Watson outlines the importance of balancing ESG-related risks and opportunities when investing in China

ARLINGTON, Va., April 20, 2021 (GLOBE NEWSWIRE) — Willis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking and solutions company, today releases two research papers that outline how institutional investors can allocate capital to China while managing environmental, social and governance (ESG)-related risks and exploring ESG-driven opportunities. Research shows that although Chinese capital markets provide diversification benefits and attractive alpha opportunities for global investors, substantial challenges on the sustainable investment (SI) front have made investors cautious at the same time. The Willis Towers Watson (WTW) study shows that by using a total portfolio approach and active management of Chinese assets, investors can gain the long-term diversification and expected return benefits from adding the Chinese...

Continue reading

Forløb af ordinær generalforsamling i Kapitalforeningen BLS Invest

Kapitalforeningen BLS Invest har i dag afholdt ordinær generalforsamling i henhold til tidligere offentliggjort dagsorden. Ledelsens beretning og årsrapporten for 2020 herunder de tidligere udbetalte foreløbige udlodninger samt bestyrelsens honorar for 2020 blev godkendt af generalforsamlingen. Til bestyrelsen genvalgtes Chris Bigler, Søren B. Andersson, Anne Christina Skjønnemand og Mikael Skov, ligesom EY Godkendt Revisionspartnerselskab genvalgtes som revisor for foreningen. Bestyrelsen konstituerede sig efterfølgende med Chris Bigler som formand. Eventuel henvendelse vedrørende denne meddelelse kan rettes til bestyrelsens formand, Chris Bigler tlf. 29 74 06 55 eller CEO Martin Udbye Madsen, tlf. 44 55 86 45. Med venlig hilsenKapitalforeningen BLS Invest Chris BiglerFormand for bestyrelsen Vedhæftet filFB_BLS_Invest_forloeb_GF_20...

Continue reading

CORRECTING AND REPLACING — Agile Therapeutics

PRINCETON, N.J., April 20, 2021 (GLOBE NEWSWIRE) — In a release issued earlier today by Agile Therapeutics, Inc. (Nasdaq: AGRX), please note the headline should read “Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2021” instead of “Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2020”. The corrected release follows: Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2021 Live Conference Call and Webcast at 4:30 p.m. EDT Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report first quarter 2021 financial results after the market close on Tuesday, May 4, 2021 as follows:Date Tuesday,...

Continue reading

CNL Strategic Capital Announces Year-End 2020 Operating Results

Orlando, Fla., April 20, 2021 (GLOBE NEWSWIRE) — CNL Strategic Capital, LLC (“CNL Strategic Capital,” the “Company” or “we”) seeks to provide current income and long-term appreciation to its investors by acquiring controlling equity stakes in combination with loan positions in privately owned middle-market businesses. The Company announced its operating results for the year ended Dec. 31, 2020, CNL Strategic Capital’s third year of operation. 2020 HighlightsCNL Strategic Capital received approximately $125.3 million from the sale of approximately 4.4 million shares during the year ended Dec. 31, 2020, bringing total gross proceeds to $291 million. As of Dec. 31, 2020, CNL Strategic Capital had approximately $314.1 million in total assets, compared with approximately $175.5 million as of Dec. 31, 2019. CNL Strategic Capital closed...

Continue reading

Beam Therapeutics Publishes Data Highlighting Ability to Rationally Design Base Editors for Precise Editing

Data Published in The CRISPR Journal Describe Inlaid Base Editors (IBEs) that Enhance Editing Efficiency and Capability, an Advancement of the Company’s Pioneering Work in Developing Base Editors Data Demonstrates Utility of IBEs in BEAM-102, Enabling Conversion of Sickle Cell Hemoglobin Allele to the Naturally Occurring, Benign HbG-Makassar Variant in Patient-derived Hematopoietic Stem Cells CAMBRIDGE, Mass., April 20, 2021 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the publication of work describing inlaid base editors (IBEs) in The CRISPR Journal. IBEs are architectural variants of base editors that have attributes of enhanced specificity and altered activity windows relative to foundational base editors. The work...

Continue reading

ScottsMiracle-Gro Announces Timing of Second Quarter 2021 Financial Results and Conference Call

MARYSVILLE, Ohio, April 20, 2021 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE SMG), one of the world’s largest marketers of branded consumer lawn and garden products, will release its second quarter financial results on Wednesday, May 5, 2021, prior to the opening of the U.S. financial markets. The Company will host a conference call to discuss those results at 9:00 a.m. ET. To participate in the conference call, please call 800-289-0438 (Conference Code: 5691876). A replay of the call can be heard by calling 888-203-1112. The replay will be available for 15 days. A live webcast of the call and the press release will be available on the Company’s investor relations website at http://investor.scotts.com. An archive of the press release and any accompanying information will remain available for at least a 12-month period. About...

Continue reading

North America Feeding Tubes Market to Reach USD 1,014.9 Million by 2028; Rapid Shift towards Enteral Feeding to Boost Growth, says Fortune Business Insights™

Pune, India, April 20, 2021 (GLOBE NEWSWIRE) — The North America feeding tubes market is set to gain momentum from the increasing shift of people towards enteral feeding from parenteral feeding because of its several benefits. It promotes the local immune function of the gut and eliminates villous atrophy. Hence, manufacturers nowadays are developing novel products to cater to the high demand. In June 2020, for instance, Applied Medical Technology, Inc. (AMT) introduced AMT ONE Source™, its latest mobile app to offer easy and quick access to the company’s educational materials. This information is given by Fortune Business Insights™ in a new report, titled, “North America Feeding Tubes Market, 2021-2028.” As per the report, the North America feeding tubes market size is expected to grow from USD 516.1 million in 2020 to USD 1,014.9...

Continue reading

View Systems, Inc.’s (VSYM) Sannabis Announces New Product to Supply the Food and Beverage Industry with Cannabis Flavorings Full of Terpenes and Flavonoids to Enhance a Products Essence and Therapeutic Value

Sannabis recently announced approvals by an Inspector from Colombia’s Ministry of Agriculture of their Seed Bank Facilities in anticipation of the Issuance of a coveted Cannabis Seed Use License. Cali, Colombia, April 20, 2021 (GLOBE NEWSWIRE) — View Systems, Inc.’s (OTC:VSYM), Sannabis S.A.S. (the “Company”), a Colombian cannabis company, announces the development of a new product to supply the food and beverage industry with Cannabis flavorings. For several years Sannabis has been producing an essential oil with a mystical therapeutic essence that captivated users with the pure aroma and flavor of the botanical components of Cannabis. Sannabis redeveloped its essential oil into a Non-THC raw material that can be used by food and drink companies to flavor potentially hundreds of different products. Recently PepsiCo announced their...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.